BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28464734)

  • 1. Beam angle evaluation to improve inter-fraction motion robustness in pelvic lymph node irradiation with proton therapy.
    Gravgaard Andersen A; Casares-Magaz O; Petersen J; Toftegaard J; Bentzen L; Thörnqvist S; Muren LP
    Acta Oncol; 2017 Jun; 56(6):846-852. PubMed ID: 28464734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for evaluation of proton plan robustness towards inter-fractional motion applied to pelvic lymph node irradiation.
    Andersen AG; Casares-Magaz O; Muren LP; Toftegaard J; Bentzen L; Thörnqvist S; Petersen JB
    Acta Oncol; 2015; 54(9):1643-50. PubMed ID: 26203931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer.
    Casares-Magaz O; Toftegaard J; Muren LP; Kallehauge JF; Bassler N; Poulsen PR; Petersen JB
    Acta Oncol; 2014 Aug; 53(8):1058-63. PubMed ID: 24975371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of beam angle choice on pencil beam scanning breath-hold proton therapy for lung lesions.
    Gorgisyan J; Perrin R; Lomax AJ; Persson GF; Josipovic M; Engelholm SA; Weber DC; Munck Af Rosenschold P
    Acta Oncol; 2017 Jun; 56(6):853-859. PubMed ID: 28464744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the influence of organ motion during photon vs. proton therapy for locally advanced prostate cancer using biological models.
    Busch K; G Andersen A; Casares-Magaz O; Petersen JBB; Bentzen L; Thörnqvist S; Muren LP
    Acta Oncol; 2017 Jun; 56(6):839-845. PubMed ID: 28464733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
    Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
    Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.
    Su Z; Li Z; Henderson R; Hoppe B; Nichols RC; Bryant C; Mendenhall W; Mendenhall N
    Phys Med Biol; 2019 Feb; 64(4):04NT04. PubMed ID: 30630135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beam angle optimization using angular dependency of range variation assessed via water equivalent path length (WEPL) calculation for head and neck proton therapy.
    Kim J; Park YK; Sharp G; Busse P; Winey B
    Phys Med; 2020 Jan; 69():19-27. PubMed ID: 31812726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Beam-Angle-Selection Method to Improve Inter-Fraction Motion Robustness for Lung Tumor Irradiation With Passive Proton Scattering.
    Zhang Y; Ho MW; Li Z
    Technol Cancer Res Treat; 2020; 19():1533033820948052. PubMed ID: 32844716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A method for acquiring random range uncertainty probability distributions in proton therapy.
    Holloway SM; Holloway MD; Thomas SJ
    Phys Med Biol; 2017 Dec; 63(1):01NT02. PubMed ID: 29053110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using CBCT for pretreatment range check in proton therapy: a phantom study for prostate treatment by anterior-posterior beam.
    Bentefour el H; Both S; Tang S; Lu HM
    J Appl Clin Med Phys; 2015 Nov; 16(6):472–483. PubMed ID: 26699545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets.
    Thörnqvist S; Muren LP; Bentzen L; Hysing LB; Høyer M; Grau C; Petersen JB
    Acta Oncol; 2013 Apr; 52(3):521-7. PubMed ID: 23409771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
    Botas P; Grassberger C; Sharp G; Paganetti H
    Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Image Guided Radiation Therapy Strategies for Pelvic Lymph Node Irradiation in High-Risk Prostate Cancer: Motion and Margins.
    Kershaw L; van Zadelhoff L; Heemsbergen W; Pos F; van Herk M
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):68-77. PubMed ID: 29051038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.
    Thörnqvist S; Bentzen L; Petersen JB; Hysing LB; Muren LP
    Acta Oncol; 2011 Aug; 50(6):926-34. PubMed ID: 21767193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.
    Zhou S; Luo L; Li J; Lin M; Chen L; Shao J; Lu S; Ma Y; Zhang Y; Chen W; Liu M; Liu S; He L
    Radiat Oncol; 2019 Jan; 14(1):22. PubMed ID: 30696488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the radiological depth correlate with dosimetric deterioration in particle therapy for stage I NSCLC patients under high frequency jet ventilation.
    Santiago A; Fritz P; Mühlnickel W; Engenhart-Cabillic R; Wittig A
    Acta Oncol; 2015; 54(9):1631-7. PubMed ID: 26228661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.
    Cantin A; Gingras L; Lachance B; Foster W; Goudreault J; Archambault L
    Med Phys; 2015 Dec; 42(12):7011-21. PubMed ID: 26632056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton therapy of prostate cancer by anterior-oblique beams: implications of setup and anatomy variations.
    Moteabbed M; Trofimov A; Sharp GC; Wang Y; Zietman AL; Efstathiou JA; Lu HM
    Phys Med Biol; 2017 Mar; 62(5):1644-1660. PubMed ID: 28166057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of bowel gas and body outline variations on total accumulated dose with intensity-modulated proton therapy in locally advanced cervical cancer patients.
    Berger T; Petersen JBB; Lindegaard JC; Fokdal LU; Tanderup K
    Acta Oncol; 2017 Nov; 56(11):1472-1478. PubMed ID: 28931343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.